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Items for this week’s EPI Update include: 
  
• Shiga-toxin producing E. coli cases on the rise  
• West Nile season is upon us  
•        Pertussis outbreak reinforces need to vaccinate health care workers  
• New ACIP recommendations on use of influenza vaccine in children  
• Meeting cancellation  
  
Shiga-toxin producing E. coli cases on the rise 
An increasing number of shiga-toxin producing E. coli cases are being reported 
to CADE. No significant clusters have been identified so far.  
Two-thirds of all cases reported in the last four weeks have occurred in persons 
aged 21 years and younger. Serotypes include O26, 111, and 103. 
  
Symptoms of shiga-toxin producing E. coli will are bloody diarrhea and 
abdominal pain; typically they do not have fever. Children and adolescents have 
the highest risk for developing complications of shiga-toxin producing E. coli 
infection, such as hemolytic uremic syndrome. Antibiotics are not recommended 
for the treatment of this disease and may increase the risk for complications.  
  
All cases of shiga-toxin producing E. coli should be immediately reported to Local 
Public Health or CADE. Specimens testing positive for shiga-toxin in suspected 
E. coli cases should be sent to the University Hygienic Laboratory for 
confirmation and serotype determination. For questions about specimen 
submission, contact UHL at 319-335-4500.  
  
West Nile season is upon us 
Mosquito trapping conducted by local officials and the Iowa State University 
Medical Entomology Department in late June and early July demonstrated that 
Aedes vexans and Aedes trivittatus, both floodwater mosquitoes, were abundant. 
These mosquitoes don’t usually transmit West Nile virus to humans. This 
increase was expected, as large numbers of flood water mosquitoes usually 
appear about one to two weeks after heavy rains and flooding.  
  
As the flood waters have receded and the standing water has concentrated, the 
overall number of mosquitoes has declined. The proportion of Culex mosquitoes 
has increased, however. Culex mosquitoes are a significant public health threat 
because they are more likely to transmit viruses such as West Nile virus.  
  
Although we have not had a confirmed case of West Nile virus in humans this 
year, nor have any of our mosquito pools or sentinel chickens tested positive for 
exposure to West Nile virus, this increase in Culex mosquitoes could be an early 
indicator of increasing viral activity. 
     
We encourage everyone to take the following measures to protect themselves 
from disease:  
Avoid mosquito bites by: 
•        Applying approved insect repellents.  
•        Wearing protective clothing, such as long-sleeves, long pants, 
socks and shoes. 
•        Being aware of peak hours of mosquito activity: dusk and dawn. 
Mosquito proof your home by: 
•     At least once or twice a week, empty water from flower pots, pet 
food and water dishes, birdbaths, swimming pool covers, buckets, 
barrels, and cans.  
•     Check for clogged rain gutters and clean them out. 
•     Remove discarded tires, and other items that could collect water. 
•     Be sure to check for containers or trash in places that may be hard 
to see, such as under bushes or under your home. 
We also encourage health care providers to remain vigilant as we enter the peak 
of our arbovirus transmission season.  Diagnostic testing in humans will continue 
to be offered at the University of Iowa Hygienic Laboratory (UHL). Indication for 
testing includes:  
•        Encephalitis cases of unknown etiology. 
•        Patients with flaccid paralysis, myelitis or neurological symptoms following 
a febrile illness. 
•        Patients with onset of compatible illness within two weeks of receiving 
blood products. 
•        Pregnant or breast-feeding women with a compatible febrile illness and 
exposure history. 
•        Aseptic meningitis cases, although at this time of year, many such cases 
are caused by enteroviruses; CSF testing by PCR for enterovirus is 
recommended.  
•        Clinically compatible illness during transmission season. Providers should 
consider if there is any clinical value in testing patients with mild fevers of 
unknown origin in the absence of neurological signs. 
UHL does NOT recommend testing of asymptomatic persons concerned 
about exposure or with mild uncomplicated febrile illness, or the screening of 
asymptomatic pregnant or breast-feeding women. 
For more information, visit: 
 www.uhl.uiowa.edu/kitsquotesforms/clinicaltestmenu.pdf.  
www.idph.state.ia.us/adper/common/pdf/flood/mosquito_checklist.pdf. 
  
Pertussis outbreak reinforces need to vaccinate health care workers 
A review of hospital-acquired pertussis outbreaks among infants at a children’s 
hospital in 2004 emphasizes the need for health care facilities to follow the 
Advisory Committee on Immunization Practices (ACIP) recommendation that all 
health care workers (HCW) receive the diphtheria and tetanus toxoids and 
acellular pertussis vaccine, according to data from a report recently published in 
the Morbidity and Mortality Weekly Report. 
Pertussis can be a serious disease in young children. Common complications in 
children younger than one year of age include seizures, pneumonia, and 
cardiovascular compromise. The case-fatality rate among newborns and infants 
aged younger than two months is 1.8 percent, according to the data.   
In 2005, the ACIP issued vaccine guidelines recommending vaccination among 
HCWs, particularly those with direct patient contact with infants aged younger 
than 12 months. Widespread implementation of this recommendation can reduce 
the risk for future pertussis transmission in health care settings.   
For more information visit: 
www.cdc.gov/mmwr/preview/mmwrhtml/mm5722a2.htm  
www.cdc.gov/mmwr/PDF/rr/rr5704.pdf
  
New ACIP recommendations on use of influenza vaccine in children 
The Advisory Committee on Immunization Practices (ACIP) met in Atlanta June 
25-26. They announced that there will be an expansion of children recommended 
for influenza vaccination during the 2008-2009 influenza seasons. Children five 
years of age through 18 years of age should be vaccinated, if feasible, against 
influenza beginning in 2008.  Children six months of age to five years of age are 
already recommended for vaccination. 
                
The six influenza manufacturers project about 150 million doses of vaccine will 
be available for the 2008-2009 influenza season.  There will be an estimated 50 
million doses of thimerosal- or preservative-free influenza vaccine available. 
  
Meeting cancellation 
The Fall EPI Updates for 2008 have been cancelled to enable CADE staff to 
deliver IDSS training. Details of IDSS training shall be released soon. 
  
Have a safe, healthy and happy week! 
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